Rapid Micro Biosystems, Inc.
RPIDNASDAQHealthcare● Active
$1.98
$-0.01(-0.50%)
Market Cap$89738114
P/E Ratio—
52W High$4.94
52W Low$1.86
Rapid Micro Biosystems, Inc. (RPID) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · RPID · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $33.59M | $28.05M | $22.52M | $17.13M | $23.23M |
| Cost of Revenue | $25.98M | $28.16M | $28.00M | $25.67M | $30.97M |
| Gross Profit | $7.61M | ($0.11M) | ($5.49M) | ($8.54M) | ($7.74M) |
| Gross Margin %(computed) | 22.65% | -0.39% | -24.36% | -49.85% | -33.32% |
| Operating Expenses | |||||
| R&D Expenses | $13.60M | $14.60M | $12.82M | $12.87M | $9.78M |
| G&A Expenses | $22.75M | $21.95M | $24.94M | $26.82M | $17.89M |
| Total Operating Expenses | $55.00M | $49.81M | $51.08M | $54.68M | $39.49M |
| Operating Income | ($47.39M) | ($49.92M) | ($56.56M) | ($63.22M) | ($47.23M) |
| Operating Margin %(computed) | -141.10% | -177.96% | -251.18% | -368.99% | -203.31% |
| Interest Income | $1.51M | $3.16M | $4.21M | $1.78M | $0.00M |
| Interest Expense | $1.09M | $0.00M | $0.00M | $0.00M | $2.65M |
| Income Before Tax | ($47.08M) | ($46.87M) | ($52.44M) | ($61.38M) | ($73.43M) |
| Income Tax Expense | $0.04M | $0.02M | $0.03M | ($0.58M) | $0.09M |
| Net Income | ($47.12M) | ($46.89M) | ($52.47M) | ($60.81M) | ($73.52M) |
| Net Margin %(computed) | -140.30% | -167.16% | -232.99% | -354.91% | -316.48% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.05 | $-1.08 | $-1.22 | $-1.43 | $-1.88 |
| Wtd Avg Shares | 44.68M | 43.58M | 43.02M | 42.45M | 41.47M |
| EBITDA | ($44.14M) | ($46.56M) | ($53.46M) | ($60.38M) | ($45.70M) |
| EBITDA Margin %(computed) | -131.42% | -165.97% | -237.39% | -352.43% | -196.72% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Rapid Micro Biosystems, Inc. data
About Rapid Micro Biosystems, Inc. (RPID) Income Statement
Rapid Micro Biosystems, Inc. (RPID) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, RPID reported revenue of $0.03B, gross profit of $0.01B (gross margin 22.65%), and net income of ($0.05B) — a net profit margin of -140.30%.
Frequently asked questions
RPID · 4 questionsRapid Micro Biosystems, Inc. (RPID) reported revenue of $0.03B for 2025, up 19.7% year-over-year.
RPID revenueRPID salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09